Unió Europea - finès - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Finlàndia - finès - Fimea (Suomen lääkevirasto)

sandoz a/s - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni

Finlàndia - finès - Fimea (Suomen lääkevirasto)

medical valley invest ab - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni